This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

O. W. BARLOW, M.D.; G. L. FIFE, M.D.; A. C. HODGINS, M.D.

Arch Surg. 1934;29(4):527-545.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Pentobarbital sodium, because of the rapidity with which sedation or hypnosis occurs after its oral administration and the short duration of its action owing to its rapid destruction in the body, appeared to be one of the most promising of the newer fixed hypnotics for preanesthetic medication from both an experimental (Fitch, Waters and Tatum;¹ Barlow, Duncan and Gledhill;² Kleindorfer, 1932) and a clinical standpoint (Lundy;³ Wilcox;⁴ Magill⁵). The marked relief from apprehensiveness and the practical absence of disagreeable associated actions, such as preoperative excitement and respiratory or circulatory depression when used in effective dosages, suggested a trial of this agent for surgical premedication in man.

The use of pentobarbital sodium in the surgical service of the University Hospitals was begun in April 1932. The procedures established by experience have become routine, and this type of premedication at the present time is administered in approximately . . . [Full Text PDF of this Article]

Author Affiliations
CLEVELAND

From the Department of Anesthesia, the University Hospitals and the Department of Pharmacology, the School of Medicine, Western Reserve University.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?